Please assess the completion status of the following clinical trial:

Trial Title: A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Type 2 Diabetes.~* Treated with a sulfonylurea for at least 2 months.~* Inadequate blood sugar control.~* Are not on any other medications to lower blood sugar.~* No major heart, liver or kidney problems.~* Women not pregnant or breast feeding.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 77 Years
- Healthy Volunteers: f

Study Arms:
- Saxagliptin 2.5 mg + Glyburide 7.5 mg (A) (Type: EXPERIMENTAL): Metformin 500-2500 mg (as needed)
- Saxagliptin 5 mg + Glyburide 7.5 mg (B) (Type: EXPERIMENTAL): Metformin 500-2500 mg (as needed)
- Placebo + Glyburide 7.5 mg (C) (Type: PLACEBO_COMPARATOR): Metformin 500-2500 mg (as needed)

Based on this trial design, predict the completion outcome and termination type (if applicable).